PCV17 A COST-UTILITY ANALYSIS OF LOSARTAN VERSUS ATENOLOL IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION
May 1, 2004, 00:00 AM
10.1016/S1098-3015(10)62383-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)62383-2/fulltext
Section Title :
Section Order :
321
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62383-2&doi=10.1016/S1098-3015(10)62383-2